Mao Mu
No. 28, Guiyi Street
Guiyang, 550001, China
Guiyang, 550001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Discovery of a pyrimidine-based steroidal FXR agonist for the treatment of metabolic dysfunction-associated steatotic liver disease.
Journal: Bioorganic chemistry
Published: January 05, 2026
Structural imbalances in EPA Perceptions: A multi-center study of cognitive differences between faculty and trainees in Chinese surgical residency training.
Journal: Surgery open science
Published: December 13, 2025
Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trial.
Journal: The Journal of infection
Published: November 10, 2024
TEC-mediated tRF-31R9J regulates histone lactylation and acetylation by HDAC1 to suppress hepatocyte ferroptosis and improve non-alcoholic steatohepatitis.
Journal: Clinical epigenetics
Published: August 05, 2024
Level and clinical significance of serum CXC chemokine ligand 13 in patients with hepatocellular carcinoma.
Journal: Translational cancer research
Published: July 27, 2024
Nintedanib attenuates NLRP3 inflammasome-driven liver fibrosis by targeting Src signaling.
Journal: International immunopharmacology
Published: July 19, 2024
Comparative study of trastuzumab modification analysis using mono/multi-epitope affinity technology with LC-QTOF-MS.
Journal: Journal of pharmaceutical analysis
Published: March 14, 2024
Tectorigenin improves metabolic dysfunction-associated steatohepatitis by down-regulating tRF-3040b and promoting mitophagy to inhibit pyroptosis pathway.
Journal: Biochemical and biophysical research communications
Published: February 27, 2024
Anlotinib Attenuates Liver Fibrosis by Regulating the Transforming Growth Factor β1/Smad3 Signaling Pathway.
Journal: Digestive diseases and sciences
Published: June 04, 2023
Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 17, 2021
MiR-571 affects the development and progression of liver fibrosis by regulating the Notch3 pathway.
Journal: Scientific reports
Published: March 25, 2021
Last Updated: 09/26/2026